Meningitis Treatment Market, Global Outlook and Forecast 2022-2028

April 2022 | 69 pages | ID: M0D69A385108EN
Market Monitor Global

Abstracts

Meningitis is an inflammation of the meninges, which cover the brain and spinal cord and are made up of dura matter. Meningitis can cause a life-threatening condition called septicaemia (blood poisoning) as well as long-term brain damage. It is most commonly caused by infections, certain injuries, drugs and cancer. Meningitis treatment basically refers to the all the procedures related to treat meningitis.

This report contains market size and forecasts of Meningitis Treatment in Global, including the following market information:

Global Meningitis Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Meningitis Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Antibiotics Agents Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Meningitis Treatment include Bausch Health Companies, Mylan N.V., Fresenius Kabi, Teva Pharmaceutical Industries, Zydus Cadila, Aurobindo Pharma, Beximco Pharmaceuticals, Hikma Pharmaceuticals and Astral SteriTech, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Meningitis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Meningitis Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Meningitis Treatment Market Segment Percentages, by Type, 2021 (%)

• Antibiotics Agents
• Antiviral Agents
• Corticosteroids
• Others

Global Meningitis Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Meningitis Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Specialty Clinics
• Others

Global Meningitis Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Meningitis Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Meningitis Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Meningitis Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Bausch Health Companies
• Mylan N.V.
• Fresenius Kabi
• Teva Pharmaceutical Industries
• Zydus Cadila
• Aurobindo Pharma
• Beximco Pharmaceuticals
• Hikma Pharmaceuticals
• Astral SteriTech
• Lupin
• MATINAS BIOPHARMA HOLDINGS
• Pfizer
• Novartis AG

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Meningitis Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Meningitis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL MENINGITIS TREATMENT OVERALL MARKET SIZE

2.1 Global Meningitis Treatment Market Size: 2021 VS 2028
2.2 Global Meningitis Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Meningitis Treatment Players in Global Market
3.2 Top Global Meningitis Treatment Companies Ranked by Revenue
3.3 Global Meningitis Treatment Revenue by Companies
3.4 Top 3 and Top 5 Meningitis Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Meningitis Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Meningitis Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Meningitis Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Meningitis Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Meningitis Treatment Market Size Markets, 2021 & 2028
  4.1.2 Antibiotics Agents
  4.1.3 Antiviral Agents
  4.1.4 Corticosteroids
  4.1.5 Others
4.2 By Type - Global Meningitis Treatment Revenue & Forecasts
  4.2.1 By Type - Global Meningitis Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Meningitis Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Meningitis Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Meningitis Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Specialty Clinics
  5.1.4 Others
5.2 By Application - Global Meningitis Treatment Revenue & Forecasts
  5.2.1 By Application - Global Meningitis Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Meningitis Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Meningitis Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Meningitis Treatment Market Size, 2021 & 2028
6.2 By Region - Global Meningitis Treatment Revenue & Forecasts
  6.2.1 By Region - Global Meningitis Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Meningitis Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Meningitis Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Meningitis Treatment Revenue, 2017-2028
  6.3.2 US Meningitis Treatment Market Size, 2017-2028
  6.3.3 Canada Meningitis Treatment Market Size, 2017-2028
  6.3.4 Mexico Meningitis Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Meningitis Treatment Revenue, 2017-2028
  6.4.2 Germany Meningitis Treatment Market Size, 2017-2028
  6.4.3 France Meningitis Treatment Market Size, 2017-2028
  6.4.4 U.K. Meningitis Treatment Market Size, 2017-2028
  6.4.5 Italy Meningitis Treatment Market Size, 2017-2028
  6.4.6 Russia Meningitis Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Meningitis Treatment Market Size, 2017-2028
  6.4.8 Benelux Meningitis Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Meningitis Treatment Revenue, 2017-2028
  6.5.2 China Meningitis Treatment Market Size, 2017-2028
  6.5.3 Japan Meningitis Treatment Market Size, 2017-2028
  6.5.4 South Korea Meningitis Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Meningitis Treatment Market Size, 2017-2028
  6.5.6 India Meningitis Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Meningitis Treatment Revenue, 2017-2028
  6.6.2 Brazil Meningitis Treatment Market Size, 2017-2028
  6.6.3 Argentina Meningitis Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Meningitis Treatment Revenue, 2017-2028
  6.7.2 Turkey Meningitis Treatment Market Size, 2017-2028
  6.7.3 Israel Meningitis Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Meningitis Treatment Market Size, 2017-2028
  6.7.5 UAE Meningitis Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Bausch Health Companies
  7.1.1 Bausch Health Companies Corporate Summary
  7.1.2 Bausch Health Companies Business Overview
  7.1.3 Bausch Health Companies Meningitis Treatment Major Product Offerings
  7.1.4 Bausch Health Companies Meningitis Treatment Revenue in Global Market (2017-2022)
  7.1.5 Bausch Health Companies Key News
7.2 Mylan N.V.
  7.2.1 Mylan N.V. Corporate Summary
  7.2.2 Mylan N.V. Business Overview
  7.2.3 Mylan N.V. Meningitis Treatment Major Product Offerings
  7.2.4 Mylan N.V. Meningitis Treatment Revenue in Global Market (2017-2022)
  7.2.5 Mylan N.V. Key News
7.3 Fresenius Kabi
  7.3.1 Fresenius Kabi Corporate Summary
  7.3.2 Fresenius Kabi Business Overview
  7.3.3 Fresenius Kabi Meningitis Treatment Major Product Offerings
  7.3.4 Fresenius Kabi Meningitis Treatment Revenue in Global Market (2017-2022)
  7.3.5 Fresenius Kabi Key News
7.4 Teva Pharmaceutical Industries
  7.4.1 Teva Pharmaceutical Industries Corporate Summary
  7.4.2 Teva Pharmaceutical Industries Business Overview
  7.4.3 Teva Pharmaceutical Industries Meningitis Treatment Major Product Offerings
  7.4.4 Teva Pharmaceutical Industries Meningitis Treatment Revenue in Global Market (2017-2022)
  7.4.5 Teva Pharmaceutical Industries Key News
7.5 Zydus Cadila
  7.5.1 Zydus Cadila Corporate Summary
  7.5.2 Zydus Cadila Business Overview
  7.5.3 Zydus Cadila Meningitis Treatment Major Product Offerings
  7.5.4 Zydus Cadila Meningitis Treatment Revenue in Global Market (2017-2022)
  7.5.5 Zydus Cadila Key News
7.6 Aurobindo Pharma
  7.6.1 Aurobindo Pharma Corporate Summary
  7.6.2 Aurobindo Pharma Business Overview
  7.6.3 Aurobindo Pharma Meningitis Treatment Major Product Offerings
  7.6.4 Aurobindo Pharma Meningitis Treatment Revenue in Global Market (2017-2022)
  7.6.5 Aurobindo Pharma Key News
7.7 Beximco Pharmaceuticals
  7.7.1 Beximco Pharmaceuticals Corporate Summary
  7.7.2 Beximco Pharmaceuticals Business Overview
  7.7.3 Beximco Pharmaceuticals Meningitis Treatment Major Product Offerings
  7.7.4 Beximco Pharmaceuticals Meningitis Treatment Revenue in Global Market (2017-2022)
  7.7.5 Beximco Pharmaceuticals Key News
7.8 Hikma Pharmaceuticals
  7.8.1 Hikma Pharmaceuticals Corporate Summary
  7.8.2 Hikma Pharmaceuticals Business Overview
  7.8.3 Hikma Pharmaceuticals Meningitis Treatment Major Product Offerings
  7.8.4 Hikma Pharmaceuticals Meningitis Treatment Revenue in Global Market (2017-2022)
  7.8.5 Hikma Pharmaceuticals Key News
7.9 Astral SteriTech
  7.9.1 Astral SteriTech Corporate Summary
  7.9.2 Astral SteriTech Business Overview
  7.9.3 Astral SteriTech Meningitis Treatment Major Product Offerings
  7.9.4 Astral SteriTech Meningitis Treatment Revenue in Global Market (2017-2022)
  7.9.5 Astral SteriTech Key News
7.10 Lupin
  7.10.1 Lupin Corporate Summary
  7.10.2 Lupin Business Overview
  7.10.3 Lupin Meningitis Treatment Major Product Offerings
  7.10.4 Lupin Meningitis Treatment Revenue in Global Market (2017-2022)
  7.10.5 Lupin Key News
7.11 MATINAS BIOPHARMA HOLDINGS
  7.11.1 MATINAS BIOPHARMA HOLDINGS Corporate Summary
  7.11.2 MATINAS BIOPHARMA HOLDINGS Business Overview
  7.11.3 MATINAS BIOPHARMA HOLDINGS Meningitis Treatment Major Product Offerings
  7.11.4 MATINAS BIOPHARMA HOLDINGS Meningitis Treatment Revenue in Global Market (2017-2022)
  7.11.5 MATINAS BIOPHARMA HOLDINGS Key News
7.12 Pfizer
  7.12.1 Pfizer Corporate Summary
  7.12.2 Pfizer Business Overview
  7.12.3 Pfizer Meningitis Treatment Major Product Offerings
  7.12.4 Pfizer Meningitis Treatment Revenue in Global Market (2017-2022)
  7.12.5 Pfizer Key News
7.13 Novartis AG
  7.13.1 Novartis AG Corporate Summary
  7.13.2 Novartis AG Business Overview
  7.13.3 Novartis AG Meningitis Treatment Major Product Offerings
  7.13.4 Novartis AG Meningitis Treatment Revenue in Global Market (2017-2022)
  7.13.5 Novartis AG Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Meningitis Treatment Market Opportunities & Trends in Global Market
Table 2. Meningitis Treatment Market Drivers in Global Market
Table 3. Meningitis Treatment Market Restraints in Global Market
Table 4. Key Players of Meningitis Treatment in Global Market
Table 5. Top Meningitis Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Meningitis Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Meningitis Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Meningitis Treatment Product Type
Table 9. List of Global Tier 1 Meningitis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Meningitis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Meningitis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Meningitis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Meningitis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Meningitis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Meningitis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Meningitis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Meningitis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Meningitis Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Meningitis Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Meningitis Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Meningitis Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Meningitis Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Meningitis Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Meningitis Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Meningitis Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Meningitis Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Meningitis Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Meningitis Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Meningitis Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Bausch Health Companies Corporate Summary
Table 31. Bausch Health Companies Meningitis Treatment Product Offerings
Table 32. Bausch Health Companies Meningitis Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Mylan N.V. Corporate Summary
Table 34. Mylan N.V. Meningitis Treatment Product Offerings
Table 35. Mylan N.V. Meningitis Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Fresenius Kabi Corporate Summary
Table 37. Fresenius Kabi Meningitis Treatment Product Offerings
Table 38. Fresenius Kabi Meningitis Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Teva Pharmaceutical Industries Corporate Summary
Table 40. Teva Pharmaceutical Industries Meningitis Treatment Product Offerings
Table 41. Teva Pharmaceutical Industries Meningitis Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Zydus Cadila Corporate Summary
Table 43. Zydus Cadila Meningitis Treatment Product Offerings
Table 44. Zydus Cadila Meningitis Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Aurobindo Pharma Corporate Summary
Table 46. Aurobindo Pharma Meningitis Treatment Product Offerings
Table 47. Aurobindo Pharma Meningitis Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Beximco Pharmaceuticals Corporate Summary
Table 49. Beximco Pharmaceuticals Meningitis Treatment Product Offerings
Table 50. Beximco Pharmaceuticals Meningitis Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Hikma Pharmaceuticals Corporate Summary
Table 52. Hikma Pharmaceuticals Meningitis Treatment Product Offerings
Table 53. Hikma Pharmaceuticals Meningitis Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Astral SteriTech Corporate Summary
Table 55. Astral SteriTech Meningitis Treatment Product Offerings
Table 56. Astral SteriTech Meningitis Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Lupin Corporate Summary
Table 58. Lupin Meningitis Treatment Product Offerings
Table 59. Lupin Meningitis Treatment Revenue (US$, Mn), (2017-2022)
Table 60. MATINAS BIOPHARMA HOLDINGS Corporate Summary
Table 61. MATINAS BIOPHARMA HOLDINGS Meningitis Treatment Product Offerings
Table 62. MATINAS BIOPHARMA HOLDINGS Meningitis Treatment Revenue (US$, Mn), (2017-2022)
Table 63. Pfizer Corporate Summary
Table 64. Pfizer Meningitis Treatment Product Offerings
Table 65. Pfizer Meningitis Treatment Revenue (US$, Mn), (2017-2022)
Table 66. Novartis AG Corporate Summary
Table 67. Novartis AG Meningitis Treatment Product Offerings
Table 68. Novartis AG Meningitis Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Meningitis Treatment Segment by Type in 2021
Figure 2. Meningitis Treatment Segment by Application in 2021
Figure 3. Global Meningitis Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Meningitis Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Meningitis Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Meningitis Treatment Revenue in 2021
Figure 8. By Type - Global Meningitis Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Meningitis Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Meningitis Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Meningitis Treatment Revenue Market Share, 2017-2028
Figure 12. US Meningitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Meningitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Meningitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Meningitis Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Meningitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Meningitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Meningitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Meningitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Meningitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Meningitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Meningitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Meningitis Treatment Revenue Market Share, 2017-2028
Figure 24. China Meningitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Meningitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Meningitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Meningitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Meningitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Meningitis Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Meningitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Meningitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Meningitis Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Meningitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Meningitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Meningitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Meningitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Bausch Health Companies Meningitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Mylan N.V. Meningitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Fresenius Kabi Meningitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Teva Pharmaceutical Industries Meningitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Zydus Cadila Meningitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Aurobindo Pharma Meningitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Beximco Pharmaceuticals Meningitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Hikma Pharmaceuticals Meningitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Astral SteriTech Meningitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Lupin Meningitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. MATINAS BIOPHARMA HOLDINGS Meningitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Pfizer Meningitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Novartis AG Meningitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)